The global dialysis market size was valued at USD 120.9 Billion in 2024, and it is expected to reach USD 180.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.09% from 2025 to 2033.
To get more information on this market, Request Sample
There is an increase in the prevalence of chronic kidney diseases (CKD) and end-stage renal disease (ESRD) among the masses across the globe. Factors, such as diabetes and hypertension, which are major risk factors for kidney disease, contribute to the growing need for dialysis treatments. Diabetes can harm the kidneys' blood arteries, which impairs their capacity to efficiently filter waste. In a similar way, high blood pressure damages the kidney by applying undue strain to its fragile filtering mechanism. Dialysis services are in high demand as more people acquire CKD and eventually ESRD on account of rising incidences of diabetes and hypertension worldwide. The International Diabetes Federation (IDF) estimates that 783 million people will have diabetes by 2045.
People are more susceptible to chronic conditions like diabetes, high blood pressure, and heart problems as they get older. These conditions are leading contributors to the development of chronic kidney disease (CKD). Dialysis is becoming essential to maintain life by performing the kidney’s filtration functions. Natural aging leads to a gradual decline in kidney function, even without specific diseases. Elderly individuals usually need more medical care and are more likely to develop CKD-causing problems. This group tends to have more frequent hospital visits, a higher need for specialized treatments, and a reliance on comprehensive healthcare services. In addition, the elderly often prefer treatment options that minimize the strain and frequency of hospital visits. As per the United Nations (UN), the number of people aged 65 years or older worldwide is projected to reach 1.6 billion in 2050.
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of robust technological advancements, major market players, and a favorable regulatory environment.
The region is known for its advanced healthcare technologies and innovative medical equipment. North America, particularly the United States, has a well-established network of research institutes and technology-driven businesses that continuously develop and enhance dialysis products and procedures. North America benefits from significant investment in research and development (R&D) activities, supported by both private enterprises and government funding. The region is home to many of the world’s leading dialysis equipment manufacturers and service providers. A strong presence of key players contributes to the development of advanced dialysis solutions. The IMARC Group reports that the United States dialysis market size is anticipated to exhibit a growth rate (CAGR) of 4.40% during 2024-2032.
The region is witnessing a marked increase in the incidence of CKD and ESRD, driven by the high prevalence of diabetes, hypertension, and an aging population. Many countries in the Asia-Pacific region, including China and India, are investing in expanding healthcare facilities while enhancing access to dialysis treatment.
Europe has one of the highest proportions of elderly populations globally, which significantly impacts the prevalence of CKD and ESRD. The aging demographic drives consistent demand for dialysis services as older adults are more susceptible to kidney-related conditions. The market is witnessing the development and adoption of advanced dialysis machines that offer features such as real time monitoring, automated adjustments, and improved filtration techniques.
Collaborations between local and international healthcare organizations are helping to bring more advanced dialysis technologies to the region. The trend of home dialysis is expanding, supported by healthcare systems that encourage self-care to reduce hospital dependency and lower healthcare costs.
The Middle East and Africa region is experiencing a surge in CKD and ESRD cases. Many patients are diagnosed at later stages because of inadequate access to preventive healthcare services. Governing authorities and private healthcare companies are investing in expanding healthcare facilities, including dialysis centers, to address the increasing demand for treatment.
Some of the leading dialysis market companies include Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co. KGaA, JMS Co. Ltd., Medtronic plc, Nikkiso Co. Ltd., NIPRO Corporation, Satellite Healthcare Inc., and Toray Industries Inc., among many others. Top players in the market are investing in R&D activities to develop advanced dialysis equipment and technologies. They are enhancing their comprehensive care approach by combining services and products to support dialysis patients. On 29 May 2024, Baxter International Inc., a global innovator in kidney care and vital organ support, announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, which is associated with an approximately 25% lower all-cause mortality risk for up to four years as compared to high-flux hemodialysis (HF HD).
Report Features | Details |
---|---|
Market Size in 2024 | USD 120.9 Billion |
Market Forecast in 2033 | USD 180.4 Billion |
Market Growth Rate (2025-2033) | 4.09% |
Units | Billion USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Types Covered |
|
Product and Services Covered |
|
End Users Covered | In-center Dialysis, Home Dialysis |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co. KGaA, JMS Co. Ltd., Medtronic plc, Nikkiso Co. Ltd., NIPRO Corporation, Satellite Healthcare Inc., Toray Industries Inc., etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |